Ignite Creation Date:
2024-05-06 @ 3:33 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04670809
Status:
UNKNOWN
Last Update Posted:
2020-12-17
First Post:
2020-12-11
Brief Title:
Safety and Efficacy Study of Clevidipine Butyrate Injection in Hypertensive Emergencies
Sponsor:
Nanjing Yoko Biomedical Co Ltd
Organization:
Nanjing Yoko Biomedical Co Ltd
Study Overview
Official Title:
A Randomized Single Blind Positive Parallel Controlled Multicenter Phase III Clinical Trial of Clevidipine Butyrate Injection in the Treatment of Hypertensive Emergencies
Status:
UNKNOWN
Status Verified Date:
2020-12
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study was to determine the efficacy and safety of clevidipine for treating Hypertensive emergenciesdefined as systolic blood pressure 180 mmHg andor diastolic blood pressure 120 mmHg accompanied by acute organ damage
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None